{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:20:49Z","timestamp":1781572849455,"version":"3.54.5"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1001\/jamaophthalmol.2018.1171","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T16:33:03Z","timestamp":1528389183000},"page":"849","source":"Crossref","is-referenced-by-count":46,"title":["Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa"],"prefix":"10.1001","volume":"136","author":[{"given":"David G.","family":"Birch","sequence":"first","affiliation":[{"name":"Retina Foundation of the Southwest, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Iannacone","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Sciences Center, Hamilton Eye Institute, Memphis"},{"name":"now with Duke University School of Medicine, Duke Eye Center, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Pennesi","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Casey Eye Institute, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron L.","family":"Lam","sequence":"additional","affiliation":[{"name":"University of Miami, Bascom Palmer Eye Institute, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Heckenlively","sequence":"additional","affiliation":[{"name":"University of Michigan, Kellogg Eye Center, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Csaky","sequence":"additional","affiliation":[{"name":"Retina Foundation of the Southwest, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Winthrop","sequence":"additional","affiliation":[{"name":"now with Duke University School of Medicine, Duke Eye Center, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiran","family":"Jayasundera","sequence":"additional","affiliation":[{"name":"University of Michigan, Kellogg Eye Center, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna K.","family":"Hughbanks-Wheaton","sequence":"additional","affiliation":[{"name":"Retina Foundation of the Southwest, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Warner","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yang","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Casey Eye Institute, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Edd","family":"Fish","sequence":"additional","affiliation":[{"name":"Retina Foundation of the Southwest, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Teske","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal L.","family":"Sklaver","sequence":"additional","affiliation":[{"name":"Retina Foundation of the Southwest, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Erker","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Casey Reading Center, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Chegarnov","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Casey Reading Center, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Smith","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Casey Reading Center, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Wahle","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"VanVeldhuisen","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McCormack","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lindblad","sequence":"additional","affiliation":[{"name":"The Emmes Corporation, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bramer","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Rose","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Zilliox","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Francis","sequence":"additional","affiliation":[{"name":"Pacific Ophthalmology Consulting"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Weleber","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Casey Eye Institute, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"eoi180022r1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.exer.2016.03.018","article-title":"Retinal remodeling in human retinitis pigmentosa.","volume":"150","author":"Jones","year":"2016","journal-title":"Exp Eye Res"},{"issue":"10","key":"eoi180022r2","doi-asserted-by":"publisher","first-page":"a017129","DOI":"10.1101\/cshperspect.a017129","article-title":"Genes and mutations causing autosomal dominant retinitis pigmentosa.","volume":"5","author":"Daiger","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"eoi180022r3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/138920211795860071","article-title":"Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking.","volume":"12","author":"Chizzolini","year":"2011","journal-title":"Curr Genomics"},{"issue":"9","key":"eoi180022r4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jamaophthalmol.2013.4160","article-title":"Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.","volume":"131","author":"Birch","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi180022r5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1167\/iovs.06-0971","article-title":"Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.","volume":"48","author":"Sandberg","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi180022r6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0002-9394(85)90351-4","article-title":"Natural course of retinitis pigmentosa over a three-year interval.","volume":"99","author":"Berson","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"eoi180022r7","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1167\/iovs.05-1443","article-title":"Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.","volume":"47","author":"Sullivan","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi180022r8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/02713683.2016.1270326","article-title":"Advances in retinal prosthetic research: a systematic review of engineering and clinical characteristics of current prosthetic initiatives.","volume":"42","author":"Cheng","year":"2017","journal-title":"Curr Eye Res"},{"issue":"1","key":"eoi180022r9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1167\/iovs.16-20398","article-title":"Retinotopic to spatiotopic mapping in blind patients implanted with the Argus II retinal prosthesis.","volume":"58","author":"Caspi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi180022r10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.9758\/cpn.2017.15.1.19","article-title":"Teratogenicity of antiepileptic drugs.","volume":"15","author":"G\u00fcveli","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"10024","key":"eoi180022r11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0140-6736(16)30013-7","article-title":"France steps up warning measures for valproate drugs.","volume":"387","author":"Casassus","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"eoi180022r12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol Rev"},{"key":"eoi180022r13","first-page":"S91","article-title":"Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.","volume":"83","author":"G\u00f6ttlicher","year":"2004","journal-title":"Ann Hematol"},{"issue":"3","key":"eoi180022r14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.ajpath.2014.11.005","article-title":"Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling.","volume":"185","author":"Kimura","year":"2015","journal-title":"Am J Pathol"},{"issue":"9","key":"eoi180022r15","doi-asserted-by":"publisher","first-page":"E1584","DOI":"10.3390\/ijms17091584","article-title":"Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration.","volume":"17","author":"Kimura","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"27","key":"eoi180022r16","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1016\/j.visres.2006.08.018","article-title":"Retinitis pigmentosa associated with rhodopsin mutations: correlation between phenotypic variability and molecular effects.","volume":"46","author":"Iannaccone","year":"2006","journal-title":"Vision Res"},{"issue":"9","key":"eoi180022r17","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1021\/ct900145u","article-title":"Computational screening of rhodopsin mutations associated with retinitis pigmentosa.","volume":"5","author":"Felline","year":"2009","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"eoi180022r18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1523\/JNEUROSCI.1647-16.2016","article-title":"Opposing effects of valproic acid treatment mediated by histone deacetylase inhibitor activity in four TransgenicX. laevis models of retinitis pigmentosa.","volume":"37","author":"Vent-Schmidt","year":"2017","journal-title":"J Neurosci"},{"issue":"1","key":"eoi180022r19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bjo.2009.175356","article-title":"Therapeutic potential of valproic acid for retinitis pigmentosa.","volume":"95","author":"Clemson","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"eoi180022r20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/bjo.2010.199893","article-title":"Authors\u2019 response.","volume":"95","author":"Tzekov","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"eoi180022r21","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2147\/OPTH","article-title":"Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study.","volume":"10","author":"Iraha","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"eoi180022r22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/bjophthalmol-2013-303084","article-title":"Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.","volume":"97","author":"Bhalla","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"eoi180022r23","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/S0161-6420(00)00356-0","article-title":"Effect of stimulus size on static visual fields in patients with retinitis pigmentosa.","volume":"107","author":"Swanson","year":"2000","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi180022r24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archopht.122.9.1297","article-title":"Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.","volume":"122","author":"Berson","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi180022r25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/archophthalmol.2010.32","article-title":"Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.","volume":"128","author":"Berson","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi180022r26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajo.2013.03.021","article-title":"Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa.","volume":"156","author":"Birch","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"eoi180022r27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2016.07.013","article-title":"Long-term follow-up of patients with retinitis pigmentosa receiving intraocular ciliary neurotrophic factor implants.","volume":"170","author":"Birch","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"eoi180022r28","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1167\/iovs.15-17786","article-title":"Docosahexaenoic acid slows visual field progression in X-linked retinitis pigmentosa: ancillary outcomes of the DHAX Trial.","volume":"56","author":"Hoffman","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi180022r29","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1167\/iovs.16-19302","article-title":"Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa: filling a need to accommodate multicenter clinical trials.","volume":"57","author":"McGuigan","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi180022r30","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1167\/iovs.07-0690","article-title":"Intersession repeatability of humphrey perimetry measurements in patients with retinitis pigmentosa.","volume":"48","author":"Kim","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi180022r31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1167\/iovs.08-2229","article-title":"Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies.","volume":"50","author":"Schiefer","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi180022r32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11749-009-0138-x","article-title":"Missing data methods in longitudinal studies: a review.","volume":"18","author":"Ibrahim","year":"2009","journal-title":"Test (Madr)"},{"issue":"388","key":"eoi180022r33","first-page":"853","article-title":"Approximations for standard errors of estimators of fixed and random effect in mixed linear models.","volume":"79","author":"Kackar","year":"1984","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"eoi180022r34","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1167\/iovs.14-15013","article-title":"A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and X-linked retinitis pigmentosa.","volume":"55","author":"Cai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi180022r35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamaophthalmol.2016.0502","article-title":"Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography.","volume":"134","author":"Hariri","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi180022r36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.5.3.6","article-title":"Reliability of a manual procedure for marking the EZ endpoint location in patients with retinitis pigmentosa.","volume":"5","author":"Ramachandran","year":"2016","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"eoi180022r37","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.ophtha.2013.01.050","article-title":"Wide-field fundus autofluorescence imaging of retinitis pigmentosa.","volume":"120","author":"Oishi","year":"2013","journal-title":"Ophthalmology"},{"key":"eoi180022r38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-319-17121-0","article-title":"Wide-field fundus autofluorescence for retinitis pigmentosa and cone\/cone-rod dystrophy.","volume":"854","author":"Oishi","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"eoi180022r39","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1167\/iovs.09-4766","article-title":"Spectrum of rhodopsin mutations in French autosomal dominant rod-cone dystrophy patients.","volume":"51","author":"Audo","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi180022r40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10633-007-9087-4","article-title":"Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update.","volume":"116","author":"Robson","year":"2008","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"eoi180022r41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.4.2.14","article-title":"VFMA: topographic analysis of sensitivity data from full-field static perimetry.","volume":"4","author":"Weleber","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"eoi180022r42","doi-asserted-by":"publisher","first-page":"e0148022","DOI":"10.1371\/journal.pone.0148022","article-title":"Structure-function modeling of optical coherence tomography and standard automated perimetry in the retina of patients with autosomal dominant retinitis pigmentosa.","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"eoi180022r43","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1364\/BOE.2.001106","article-title":"Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa.","volume":"2","author":"Hood","year":"2011","journal-title":"Biomed Opt Express"},{"issue":"8","key":"eoi180022r44","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1167\/iovs.09-4945","article-title":"A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa.","volume":"51","author":"Rangaswamy","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi180022r45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.5.5.10","article-title":"Test-retest variability of functional and structural parameters in patients with stargardt disease participating in the SAR422459 Gene Therapy Trial.","volume":"5","author":"Parker","year":"2016","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"eoi180022r46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.3.5.5","article-title":"Test-retest intervisit variability of functional and structural parameters in X-linked retinoschisis.","volume":"3","author":"Jeffrey","year":"2014","journal-title":"Transl Vis Sci Technol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2683729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:30:29Z","timestamp":1547677829000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.1171"}},"subtitle":["A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1171","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}